Cite
APA Citation
Bhagunde, P., Colon‐Gonzalez, F., Liu, Y., Wu, J., Xu, S. S., Garrett, G., Jumes, P., Lasseter, K., Marbury, T., Rizk, M. L., Lala, M., Rhee, E. G., Butterton, J. R., & Boundy, K. (2020). impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin. British journal of clinical pharmacology, 86(5), 944–957. http://access.bl.uk/ark:/81055/vdc_100103687134.0x000046